Supplementary Data: STK1p as a prognostic biomarker for overall survival in non-small cell lung carcinoma, based on real-world-data..docx

Supplementary Material. STK1p as a prognostic biomarker for overall survival in non-small cell lung carcinoma, based on real-world-data. Although the patients of early stages (I-IIIA) showed a good prognosis with high OS rates (Table 1, figure 1B), it was noted that 3 patients of stage IIA-IIB died within 14-20 months after end of the treatment. We observed that the STK1p values after 2-cycle individual-chemotherapy did not returned to normal values (<0.6 pM), characterized as NR (no response, SD) by CT examination. The main reason for the death might be development of metastasis. Here we report a case analysis of these three patients to prove the significant correlations between STK1p values and clinical data in this RWD study.